Scholarlink

<p>The strategic integration of micro/nano-engineering with controlled optical responses is pivotal for advancing solid tumor therapy. We have constructed a biomimetic nanosystem via the precise encapsulation of a flexible-chain iridium complex (IrC8) within giant plasma membrane vesicles (GPMVs) derived from tumor cells. This micro/nano-scale design leverages the endogenous structure of GPMVs to achieve superior biocompatibility and enhance homologous targeting, resulting in a 4.7% increase in cellular uptake compared to the free complex. The encapsulated IrC8 complex serves as a highly efficient photosensitizer, exhibiting a strong optical response characterized by an aggregation-induced emission enhancement factor (I/I₀) &gt; 10 and a high singlet-oxygen quantum yield (ΦΔ = 0.18). Upon photoactivation, this system generates reactive oxygen species (ROS) with an 18-fold increase in yield, leading to potent phototoxicity with over 90% tumor cell apoptosis. Furthermore, the systematic integration of the vesicular carrier and the photosensitizer initiates a cascade reaction: the photodynamic effect not only directly eradicates tumor cells but also triggers immunogenic cell death (ICD), leading to potent immune activation. This synergistic combination of targeted delivery, photodynamic therapy, and immune stimulation within a single nanosystem demonstrates a remarkable synergistic therapeutic effect against solid tumors.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Iridium complex-loaded biomimetic vesicles enable enhanced photodynamic therapy and immune modulation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月19日

查看全文
  • Zhang Xiaohui,
  • Tang Xuelin,
  • Lin Bai,
  • Rui Zhao,
  • Yaohui Chen,
  • Xiaohe Tian

摘要

The strategic integration of micro/nano-engineering with controlled optical responses is pivotal for advancing solid tumor therapy. We have constructed a biomimetic nanosystem via the precise encapsulation of a flexible-chain iridium complex (IrC8) within giant plasma membrane vesicles (GPMVs) derived from tumor cells. This micro/nano-scale design leverages the endogenous structure of GPMVs to achieve superior biocompatibility and enhance homologous targeting, resulting in a 4.7% increase in cellular uptake compared to the free complex. The encapsulated IrC8 complex serves as a highly efficient photosensitizer, exhibiting a strong optical response characterized by an aggregation-induced emission enhancement factor (I/I₀) > 10 and a high singlet-oxygen quantum yield (ΦΔ = 0.18). Upon photoactivation, this system generates reactive oxygen species (ROS) with an 18-fold increase in yield, leading to potent phototoxicity with over 90% tumor cell apoptosis. Furthermore, the systematic integration of the vesicular carrier and the photosensitizer initiates a cascade reaction: the photodynamic effect not only directly eradicates tumor cells but also triggers immunogenic cell death (ICD), leading to potent immune activation. This synergistic combination of targeted delivery, photodynamic therapy, and immune stimulation within a single nanosystem demonstrates a remarkable synergistic therapeutic effect against solid tumors.